B. Braun News

Product Quick Finder

Choose a category or subcategory

B. Braun Study- INS Spring 2018

B. Braun Study Creates Industry Benchmarks to Help Minimize Alarm Fatigue In Hospital Setting

BETHLEHEM, PA – May 18, 2018 – B. Braun Medical Inc.’s Clinical Services and Scientific Affairs Teams have conducted an exploratory study to establish benchmark hospital alarm data. The preliminary findings will be presented during the poster presentations at the Infusion Nurses Society (INS) Annual Meeting, May 19-22, at the Huntington Convention Center in Cleveland, Ohio.

Data from B. Braun’s Outlook® 400ES, large volume infusion pump, with its accompanying DoseTrac® Infusion Management Software were analyzed from 32 U.S. - based hospitals between April 2014 and February 2017. B. Braun’s Clinical Services and Scientific Affairs Teams evaluated the Outlook 400ES alarm frequency as it pertained to duration and alarm type. The issue of alarm fatigue is becoming a major concern for healthcare providers as more devices are implemented in the healthcare environment.1

“The number of medical devices emitting alarms in a hospital setting that require intervention has significantly increased over the past 30 years,” said Wes Cetnarowski, Chief Medical Officer and Senior Vice President of Scientific Affairs at B. Braun. “The overall clinical impact of our data will highlight specific incidences and characteristics of infusion pump alarms which may help improve patient care.”                                                                                                                                                             

B. Braun also has conducted an additional exploratory study to understand nurses’ perception of pump alarms in the hospital setting. The findings of this study will be published later this year.  

About B. Braun 

B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include ostomy and wound care, dialysis, nutrition, pharmacy admixture and compounding. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes

B. Braun Interventional Systems, Aesculap® and CAPS®.

Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. 


1Cho OM et al. Clinical alarms in intensive care units: Perceived obstacles of alarm management and alarm fatigue in nurses. Healthc Inform Res. 2016; 22(1): 46-53